Thermo Fisher invests Rs 160 crore to expand Bengaluru R&D centre

R&D

US-based Thermo Fisher Scientific, the world’s largest life sciences tools company, has expanded its R&D footprint in India with a Rs 160 crore investment in its Bengaluru Centre of Excellence.

The newly inaugurated 37,000 sq. ft. facility will focus on advancing antibody design, development, and manufacturing, integrating cutting-edge automation and analytical platforms to support immunoassays, protein analysis, and cell-based studies. The expansion is expected to create over 100 high-skilled jobs in the coming years.

“This expansion reflects our long-term commitment to India’s innovation ecosystem,” said Gianluca Pettiti, Executive Vice President and Sector President, Life Sciences, Diagnostics and Applied Sector at Thermo Fisher.

“By investing in talent and capabilities here, we will accelerate scientific progress and better serve customers in India and globally,” Pettiti added.

The Bengaluru site has played important role for Thermo Fisher’s global R&D network for nearly two decades. It has developed over 2,000 recombinant antibodies and validated more than 25,000, contributing to breakthroughs in infectious diseases, cancer biology, and antiviral research, Thermo Fisher said in a release.

Its manufacturing capabilities have delivered thousands of primary and secondary antibodies to researchers worldwide.

“This expansion reinforces our belief in India’s potential to lead in life sciences innovation,” said Manoj Prasad, Vice President, IT & Digital Solutions, APAC & MEA.

“With this infrastructure and talent infusion, we can accelerate discovery and strengthen our global network.”

Thermo Fisher employs more than 1,400 professionals in Bengaluru across R&D, software, and scientific product teams. The city’s deep talent pool and infrastructure have made it a strategic anchor for the company’s operations in South Asia.

The expansion also aligns with Thermo Fisher’s broader strategy to integrate discovery, design, and manufacturing under one roof, enabling faster innovation cycles and enhanced support for customers in biotech, diagnostics, and academia.